Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|December 2, 2006
Immunobiology of the sentinel lymph node and its potential role for antitumour immunityRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.
Cancer Research|June 3, 2006
Tumor-driven evolution of immunosuppressive networks during malignant progressionRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Therapeutic potential of antisense (AS) Bcl-2 as a chemosensitizer for patients with gastric and breast carcinoma]Ryungsa Kim, Manabu Emi, Kazuo Matsuura, et al.
Anti-Cancer Drugs|October 11, 2003
Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitationsRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.
International Journal of Oncology|December 5, 2003
Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review)Ryungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
International Journal of Molecular Medicine|May 9, 2003
Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinomaRyungsa Kim, Kazuaki Tanabe, Yoko Uchida, et al.
Breast Cancer Research : BCR|November 11, 2005
Targeted therapy against Bcl-2-related proteins in breast cancer cellsManabu Emi, Ryungsa Kim, Kazuaki Tanabe, et al.
Oncology Reports|October 10, 2003
Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cellsRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Pageof 6